Navigation Links
Neogen's Rapid Test for Salmonella enteritidis Receives AOAC Approval
Date:11/8/2010

LANSING, Mich., Nov. 8, 2010 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) today announced that its rapid test for Salmonella enteritidis (SE) has received approval from AOAC International.

Neogen's newly approved test kit, Reveal® for Salmonella enteritidis, provides the egg industry with a quick, accurate and easy method of detecting this pathogen, as the U.S. Food and Drug Administration implements new SE-regulations. The AOAC's process validated the accuracy of the Reveal for SE system when testing either environmental or egg samples.

"The AOAC's approval further validates our test as an invaluable tool to egg producers, as they comply with the FDA's new regulations, and seek to further reduce the likelihood of SE-contaminated eggs reaching consumers," said Ed Bradley, Neogen's vice president of Food Safety. "Until our introduction of an effective rapid test for SE, the industry had to wait up to 7 days for an outside laboratory's test results. Reveal for SE enables the industry to get results within 48 hours — and provides the rapid, accurate answer they need to manage their flocks and egg production."  

Reveal for SE is the only rapid test available for SE that follows the FDA's sample enrichment protocol and has received AOAC approval. Neogen, in cooperation with USDA scientists, began the development of this test in 2000.

"Using a rapid test for SE that uses the same sample enrichment protocol as the FDA not only allows analysts to quickly screen out negative test results, but also is compatible with the FDA confirmation process by using the same enriched samples," said Bradley. "Especially now, with the heightened concern for contaminated eggs, time is of the essence."  

The foodborne illness caused by SE is generally due to eating raw, incompletely cooked, or recontaminated eggs. Ingestion of SE-contaminated poultry meat is the second leading cause of this illness.

Neogen's comprehensive line of products it offers to the poultry industry also includes a full line of agricultural cleaners and disinfectants, and rodenticides, to stop the spread of infectious disease from animal to animal, and from production facilities to the consumer.

Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases, and sanitation concerns, and dehydrated culture media. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry
2. Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
3. Rapid Increase in the Number of Worldwide Nanotechnology Degree Programs
4. Celsis Rapid Detections Updated Drug Master Files (DMFs) Accepted by FDA
5. An optical traffic cop for rapid communication
6. Maine Medical Center Chooses Business Intelligence Solution from Rapid Insight Inc.
7. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
8. Wound Management Technologies, Inc. Rapidly Expands Its International Presence
9. Study: Era of Rapid Growth in Biomedical Research Over
10. Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM(R) Kit is a Reliable, Rapid Method for Extracting DNA From Saliva
11. Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):